Arkolith/Insider Trading/GLYC/Form 4

Rock Edwin

Chief Medical OfficerGLYCOMIMETICS INC (GLYC) · full profile →Form 4 · filed Sep 25, 2023
Net Buying
Open-Market Buys
$90K
Open-Market Sells
$0
Net Open-Market Flow
$90K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 22, 2023Buy(P)30K$1.38$42K375K
Sep 21, 2023Buy(P)35K$1.38$48K345K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-050476) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML